Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism
about
The association of four common polymorphisms from four candidate genes (COX-1, COX-2, ITGA2B, ITGA2) with aspirin insensitivity: a meta-analysisCoronary stent thrombosis related to aspirin resistance: what are the underlying mechanisms?rs5911 and rs3842788 Genetic Polymorphism, Blood Stasis Syndrome, and Plasma TXB2 and hs-CRP Levels Are Associated with Aspirin Resistance in Chinese Chronic Stable Angina PatientsPharmacogenetics of aspirin resistance: a comprehensive systematic review.The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis.The genetic basis of antiplatelet and anticoagulant therapy: A pharmacogenetic review of newer antiplatelets (clopidogrel, prasugrel and ticagrelor) and anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban).Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity.
P2860
Q26860958-F4A84A0A-5C85-406A-944E-1C7F5071AFE0Q28210440-C2AEAD31-EE31-4600-B0D5-A0DD5BF17D3EQ33561276-1D6970C0-4297-46B7-81A2-7A1D84872F81Q37145122-E8E0983C-35EA-4E19-8591-297840C700AFQ38120047-A2A3978D-9C36-42C8-9BCA-DDE18E69B735Q38750444-E0E617B4-2B29-48B0-B715-0DF39E5D8D75Q46718851-5932EE9B-63C0-4C9E-9D6E-A98CF1A001D5
P2860
Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@ast
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@en
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@nl
type
label
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@ast
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@en
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@nl
prefLabel
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@ast
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@en
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@nl
P2860
P1433
P1476
Aspirin resistance in coronary ...... m or the PlA(1/2) polymorphism
@en
P2093
Johannes Ruef
Roger Kranzhofer
P2860
P356
10.1080/09537100500441101
P407
P577
2006-05-01T00:00:00Z